Thermo Fisher Scientific Stock News

Enzyme-linked immunosorbent assay (ELISA) is a labeled immunoassay that is considered the gold standard of immunoassays. This immunological test is very sensitive and is used to detect and quantify substances, including antibodies, antigens, proteins, glycoproteins, and hormones. The enzyme-linked immunosorbent assay

The Global Laboratory Equipment Market Continues To Grow Owing To the Expansion of Laboratories in the World Laboratory Equipment Market, By Equipment Type (General Instrument, Analytical Instrument, Specialty Instrument), By End User (Academic Laboratory, Research Laboratory, Pharmaceutical Laboratory) - Global

According to the new market research report Therapeutic Drug Monitoring Market by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User Global Forecast to 2025, published by MarketsandMarkets, the TDM Market is projected to reach USD 2.0 billion by 2025 from USD 1.4 billion in 2020, at []

Bogart Wealth LLC grew its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 11.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 173 shares of the medical research companys stock after buying an additional 18 shares during the []

AdvisorNet Financial Inc lowered its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 41.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,384 shares of the medical research companys stock after selling 5,870 shares during the period. AdvisorNet []

Geneva Partners LLC boosted its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 9.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 5,213 shares of the medical research companys stock after buying an additional 460 shares during the period. Thermo Fisher Scientific makes up about 1.4% of []

The global sepsis diagnostics market is expected to witness growth due to an increase in hospital-acquired infections over the forecast period. For instance, according to data from the Centers for Disease Control and Prevention (CDC), in 2019, there had been

Thrivent Financial for Lutherans trimmed its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 4.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 328,979 shares of the medical research companys stock after selling 14,072 shares during the quarter. Thrivent Financial for []

Global Thrombin Time Testing Market Synopsis: A realistic Thrombin Time Testing Market research report contains most recent Market information with which companies can have in depth analysis of Healthcare industry and future trends. It becomes easy to figure out brand awareness

Global Biochips Market Overview: The top-notch Biochips Market research report has been structured by skilful and experienced team players who work hard to accomplish an absolute growth and success in the business. The Marketing report acts upon Market study and analysis

Key Prominent Players Covered in the CDMO Market are Catalent, Inc , Baxter, Vetter, Recipharm AB, Albany Molecular Research Inc. (AMRI), Thermo Fisher Scientific Inc. (Patheon), Unither, DPT LABORATORIES LTD., NextPharma Technologies, Others. Key Prominent Players Covered in the CDMO Market are Catalent, Inc , Baxter, Vetter, Recipharm AB, Albany Molecular Research Inc. (AMRI), Thermo Fisher Scientific Inc. (Patheon), Unither, DPT LABORATORIES LTD., NextPharma Technologies, Others.

GENEVA: The Omicron variant is likely to spread internationally, posing a "very high" global risk where COVID-19 surges could have "severe consequences" in some areas, the World Health Organisation (WHO) said on Monday. The UN agency, in technical advice to its 194 member states, urged them to accelerate vaccination of high-priority groups and to "ensure mitigation plans are in place" to maintain essential health services. "Omicron has an unprecedented number of spike mutations, some of which are concerning for their potential impact on the trajectory of the pandemic," the WHO said. "The overall global risk related to the new variant of concern Omicron is assessed as very high." Further research is needed to better understand Omicron''s potential to escape protection against immunity induced by vaccines and previous infections, it said, adding that more data was expected in coming weeks. Thermo Fisher says its COVID-19 tests accurately detects Omicron variant "COVID -19 cases and infections are expected in vaccinated persons, albeit in a small and predictable proportion", it added.

Qurates most recent research report on Tumor Tracking Systems was performed by extremely qualified research professionals and business experts in order to provide an in-depth assessment on the market. The study on Tumor Tracking Systems is extensive and consist of

Thermo Fisher Scientific Inc said on Monday its COVID-19 diagnostic tests can accurately detect the new coronavirus variant Omicron that has made several countries to shut their borders. The World Health Organisation (WHO) last week classified the Omicron variant as a SARS-CoV-2 "variant of concern," saying it may spread more quickly than other forms. Thermo Fisher''s TaqPath COVID-19 assays can report accurate results even in the case where one of the gene targets is impacted by a mutation, the company said in a statement. "This assay can be used not only to successfully detect COVID-19 but_ it also be used as a proxy for the variant," Mark Stevenson, chief operating officer at Thermo Fisher Scientific, said in an interview. Stevenson said this is the only COVID-19 diagnostic test authorized by the US Food and Drug Administration and currently in use by health systems that can be used to indicate if a case is caused by the Omnicron variant. Test samples must still be sent to a lab for sequencing to confirm that the case was caused by Omnicron and not another variant with similar features, such as the Alpha variant, he said.

WALTHAM, Mass., Nov. 29, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit*, and TaqPath COVID-19 CE-IVD RT-PCR Kit*, which test for the presence of